Combining selected immunomodulatory Propionibacterium freudenreichii and Lactobacillus delbrueckii strains: Reverse engineering development of an anti-inflammatory cheese

Molecular Nutrition and Food Research

Volumn 60, Issue 4, 2016, Pages 935-948

  Plé, Coline ^a   Breton, Jérôme ^a   Richoux, Romain ^b   Nurdin, Marine ^b   Deutsch, Stéphanie Marie ^b,c   Falentin, Hélène ^b,c   Hervé, Christophe ^d   Chuat, Victoria ^b,c,e   Lemée, Riwanon ^d   Maguin, Emmanuelle ^f,g   Jan, Gwénaël ^b,c   Van de Guchte, Maarten ^f,g   Foligné, Benoit ^a  

^a INSERM U1019   (France)

^b AGROCAMPUS OUEST   (France)

^c UMR1253   (France)

^d Laboratoires Standa   (France)

^e CIRM BIA   (France)

^f CEMAGREF   (France)

^g UMR1319 MICALIS   (France)

Author keywords

Colitis; Dairy Starter; Gut; Inflammation; Probiotic

Indexed keywords

BIOLOGICAL MARKER; NONSTEROID ANTIINFLAMMATORY AGENT; PROBIOTIC AGENT; TRINITROBENZENESULFONIC ACID;

ANIMAL; BAGG ALBINO MOUSE; BLOOD; BODY WEIGHT; CHEESE; CHEMICALLY INDUCED; COLITIS; COLON; DRUG EFFECTS; FEMALE; FERMENTATION; GENETICS; IMMUNOLOGY; INTESTINE FLORA; LACTOBACILLUS DELBRUECKII; METABOLISM; MICROBIOLOGY; OXIDATIVE STRESS; PATHOLOGY; PROPIONIBACTERIUM FREUDENREICHII;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOMARKERS; BODY WEIGHT; CHEESE; COLITIS; COLON; FEMALE; FERMENTATION; GASTROINTESTINAL MICROBIOME; LACTOBACILLUS DELBRUECKII; MICE, INBRED BALB C; OXIDATIVE STRESS; PROBIOTICS; PROPIONIBACTERIUM FREUDENREICHII; TRINITROBENZENESULFONIC ACID;

EID: 84952674116     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500580     Document Type: Article

References (44)

1. Ghouri, Y. A., Richards, D. M., Rahimi, E. F., Krill, J. T. et al., Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clin. Exp. Gastroenterol. 2014, 7, 473-487.
2. Hartley, M. G., Hudson, M. J., Swarbrick, E. T., Hill, M. J. et al., The rectal mucosa-associated microflora in patients with ulcerative colitis. J. Med. Microbiol. 1992, 36, 96-103.
3. Duboc, H., Rajca, S., Rainteau, D., Benarous, D. et al., Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 2013, 62, 531-539.
4. David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B. et al., Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505, 559-563.
5. Plé, C., Breton, J., Daniel, C., Foligne, B., Maintaining gut ecosystems for health: are transitory food bugs stowaways or part of the crew? Int. J. Food Microbiol. 2015, 213, 139-143.
6. Foligné, B., Nutten, S., Grangette, C., Dennin, V. et al., Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol. 2007, 13, 236-243.
7. Kato, K., Mizuno, S., Umesaki, Y., Ishii, Y. et al., Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment. Pharmacol. Ther. 2004, 20, 1133-1141.
8. Matthes, H., Krummenerl, T., Giensch, M., Wolff, C. et al., Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complement Altern. Med. 2010, 10, 13, 1-8.
9. Rembacken, B. J., Snelling, A. M., Hawkey, P. M., Chalmers, D. M. et al., Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999, 354, 635-639.
10. Fujimori, S., Gudis, K., Mitsui, K., Seo, T. et al., A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition 2009, 25, 520-525.
11. Saez-Lara, M. J., Gomez-Llorente, C., Plaza-Diaz, J., Gil, A., The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Biomed. Res. Int. 2015, 2015, 505878, 1-15.
12. Plé, C., Adouard, N., Breton, J., Dewulf, J. et al., Designing specific cheese-ripening ecosystems to shape the immune effects of dairy products? J. Funct. Foods 2015, 12, 219-229.
13. Hosoya, T., Sakai, F., Yamashita, M., Shiozaki, T. et al., Lactobacillus helveticus SBT2171 Inhibits lymphocyte proliferation by regulation of the JNK signaling pathway. PLoS ONE 2014, 9, e108360.
14. Yamashita, M., Ukibe, K., Uenishi, H., Hosoya, T. et al., Lactobacillus helveticus SBT2171, a cheese starter, regulates proliferation and cytokine production of immune cells. J. Dairy Sci. 2014, 97, 4772-4779.
15. Foligné, B., Deutsch, S. M., Breton, J., Cousin, F. J. et al., Promising immunomodulatory effects of selected strains of dairy propionibacteria as evidenced in vitro and in vivo. Appl. Environ. Microbiol. 2010, 76, 8259-8264.
16. Okada, Y., Tsuzuki, Y., Miyazaki, J., Matsuzaki, K. et al., Propionibacterium freudenreichii component 1.4-dihydroxy-2-naphthoic acid (DHNA) attenuates dextran sodium sulphate induced colitis by modulation of bacterial flora and lymphocyte homing. Gut 2006, 55, 681-688.
17. Okada, Y., Hokari, R., Kato, S., Mataki, N. et al., 1.4-dihydroxy-2-naphthoic acid (DHNA) shows anti-inflammatory effect on NSAID-induced colitis in IL-10-knockout mice through suppression of inflammatory cell infiltration and increased number of genus Bifidobacterium. Gastroenterology 2006, 130, A313.
18. Le Marechal, C., Peton, V., Ple, C., Vroland, C. et al., Surface proteins of Propionibacterium freudenreichii are involved in its anti-inflammatory properties. J. Proteomics. 2015, 113C, 447-461.
19. Suzuki, A., Mitsuyama, K., Koga, H., Tomiyasu, N. et al., Bifidogenic growth stimulator for the treatment of active ulcerative colitis: a pilot study. Nutrition 2006, 22, 76-81.
20. Santos Rocha, C., Gomes-Santos, A. C., Garcias-Moreira, T., de Azevedo, M. et al., Local and systemic immune mechanisms underlying the anti-colitis effects of the dairy bacterium Lactobacillus delbrueckii. PLoS ONE 2014, 9, e85923.
21. Santos Rocha, C., Lakhdari, O., Blottiere, H. M., Blugeon, S. et al., Anti-inflammatory properties of dairy lactobacilli. Inflamm. Bowel. Dis. 2012, 18, 657-666.
22. Foligné, B., Breton, J., Mater, D., Jan, G., Tracking the microbiome functionality: focus on Propionibacterium species. Gut 2013, 62, 1227-1228.
23. De Man, J. D., Rogosa, M., Sharpe, M. E., A medium for the cultivation of lactobacilli. J. Appl. Bacteriol. 1960, 23, 130-135.
24. Malik, A. C., Reinbold, G. W., Vedamuthu, E. R., An evaluation of the taxonomy of Propionibacterium. Can. J. Microbiol. 1968, 14, 1185-1191.
25. Cousin, F. J., Louesdon, S., Maillard, M. B., Parayre, S. et al., The first dairy product exclusively fermented by Propionibacterium freudenreichii: a new vector to study probiotic potentialities in vivo. Food Microbiol. 2012, 32, 135-146.
26. Madec, M. N., Rouault, A., Maubois, J. L., Thierry, A., INRA, Milieu sélectif et procédé pour le dénombrement des bactéries propioniques. Brevet. FR. 2. 700. 778. - A1. 1993, 15.
27. Falentin, H., Henaff, N., Le, B. P., Deutsch, S. M. et al., Reverse transcription quantitative PCR revealed persistency of thermophilic lactic acid bacteria metabolic activity until the end of the ripening of Emmental cheese. Food Microbiol. 2012, 29, 132-140.
28. Drouault-Holowacz, S., Foligne, B., Dennin, V., Goudercourt, D. et al., Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolerance: in vitro and in vivo considerations. Clin. Nutr. 2006, 25, 994-1003.
29. Wallace, J. L., MacNaughton, W. K., Morris, G. P., Beck, P. L., Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 1989, 96, 29-36.
30. Ameho, C. K., Adjei, A. A., Harrison, E. K., Takeshita, K. et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut 1997, 41, 487-493.
31. Bradley, P. P., Priebat, D. A., Christensen, R. D., Rothstein, G., Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 1982, 78, 206-209.
32. Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K. et al., QIIME allows analysis of high-hroughput community sequencing data. Nat. Methods 2010, 7, 335-336.
33. Dubuquoy, L., Rousseaux, C., Thuru, X., Peyrin-Biroulet, L. et al., PPARgamma as a new therapeutic target in inflammatory bowel diseases. Gut 2006, 55, 1341-1349.
34. Viladomiu, M., Hontecillas, R., Yuan, L., Lu, P. et al., Nutritional protective mechanisms against gut inflammation. J. Nutr. Biochem. 2013, 24, 929-939.
35. Huang, C. H., Hou, Y. C., Yeh, C. L., Yeh, S. L., A soybean and fish oil mixture with different n-6/n-3 PUFA ratios modulates the inflammatory reaction in mice with dextran sulfate sodium-induced acute colitis. Clin. Nutr. 2015, 34, 1018-1024.
36. Yamamoto-Furusho, J. K., Jacintez-Cazares, M., Furuzawa-Carballeda, J., Fonseca-Camarillo, G., Peroxisome proliferator-activated receptors family is involved in the response to treatment and mild clinical course in patients with ulcerative colitis. Dis. Markers 2014, 2014, 932530, 1-7.
37. Cousin, F. J., Foligne, B., Deutsch, S. M., Massart, S. et al., Assessment of the probiotic potential of a dairy product fermented by Propionibacterium freudenreichii in piglets. J. Agric. Food Chem. 2012, 60, 7917-7927.
38. Plé, C., Richoux, R., Jardin, J., Nurdin, M. et al., Single-strain starter experimental cheese reveals antiinflammatory effect of Propionibacterium freudenreichii in TNBS colitis model. J. Funct. Foods 2015, 18, 575-585.
39. Falentin, H., Deutsch, S. M., Loux, V., Hammani, A. et al., Permanent draft genome of the probiotic strain Propionibacterium freudenreichii CIRM-BIA 129 (ITG P20). Stand. Genomic. Sci. 2014, Accepted.
40. El Kafsi, H., Binesse, J., Loux, V., Buratti, J. et al., Genome sequence of Lactobacillus delbrueckii subsp. lactis CNRZ327, a dairy bacterium with anti-inflammatory properties. Genome Announc. 2014, Jul 17;2. pii: e00328-14. doi: 10.1128/genomeA.00328-14.
41. Yin, X., Yan, Y., Kim, E. B., Lee, B. et al., Short communication: effect of milk and milk containing Lactobacillus casei on the intestinal microbiota of mice. J. Dairy Sci. 2014, 97, 2049-2055.
42. Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B. et al., Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008, 455, 1109-1113.
43. Lee, B., Yin, X., Griffey, S. M., Marco, M. L., Attenuation of colitis by Lactobacillus casei BL23 is dependent on the dairy delivery matrix. Appl. Environ. Microbiol. 2015 Sep;81:6425-35. doi: 10.1128/AEM.01360-15.
44. Castro, J. M., Tornadijo, M. E., Fresno, J. M., Sandoval, H., Biocheese: a food probiotic carrier. Biomed. Res. Int. 2015, 2015, 723056, 1-11.